Literature DB >> 27864563

A replication study and meta-analysis of mitochondrial DNA variants in the radiographic progression of knee osteoarthritis.

Mercedes Fernández-Moreno1,2, Angel Soto-Hermida1, María E Vázquez-Mosquera1, Estefanía Cortés-Pereira1, Sonia Pértega3, Sara Relaño4, Natividad Oreiro-Villar1, Carlos Fernández-López1, Francisco J Blanco1, Ignacio Rego-Pérez5.   

Abstract

OBJECTIVE: To conduct a replication study and meta-analysis involving the study of mtDNA variants in the radiographic progression of OA in different cohorts worldwide, including Cohort Hip and Cohort Knee (CHECK), the OA Initiative and a cohort from Spain.
METHODS: The influence of the haplogroups in the rate of radiographic progression at 96 months in 431 subjects from CHECK was assessed in terms of Kellgren and Lawrence (KL) grade. Progression was defined as a change from KL ⩾ 1 at baseline to any higher grade during the follow-up. Extended Cox proportional hazard models were used to analyse the influence of mtDNA variants in the rate of radiographic knee OA progression. A subsequent meta-analysis of 1603 subjects following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines was conducted to combine the data of individual studies. A sensitivity analysis was performed to validate the stability of the results.
RESULTS: CHECK subjects carrying the haplogroup T showed the lowest rate of radiographic knee OA progression [hazard ratio (HR) 0.645 (95% CI 0.419, 0.978); P < 0.05]. When pooled, subjects within the superhaplogroup JT showed the same trend [HR 0.707 (95% CI 0.501, 0.965); P < 0.05]. BMI [HR 1.046 (95% CI 1.018, 1.073); P < 0.05] and bilateral OA [HR 2.266 (95% CI 1.733, 2.954); P < 0.05] at baseline are risk factors for radiographic knee OA progression as well. In the meta-analysis there was a reduced rate of radiographic progression in subjects with haplogroup T [HR 0.612 (95% CI 0.454, 0.824); P = 0.001] or in the superhaplogroup JT [HR 0.765 (95% CI 0.624, 0.938); P = 0.009]. Sensitivity analysis revealed that the results were robust.
CONCLUSION: The mtDNA variants in the superhaplogroup JT associate with a reduced rate of radiographic OA progression. The mtDNA polymorphisms in the superhaplogroup JT emerge as potential complementary genetic biomarkers for disease progression.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  genetics; knee; meta-analysis; molecular biology; osteoarthritis

Mesh:

Substances:

Year:  2016        PMID: 27864563      PMCID: PMC5854036          DOI: 10.1093/rheumatology/kew394

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  42 in total

1.  Effects of purifying and adaptive selection on regional variation in human mtDNA.

Authors:  Eduardo Ruiz-Pesini; Dan Mishmar; Martin Brandon; Vincent Procaccio; Douglas C Wallace
Journal:  Science       Date:  2004-01-09       Impact factor: 47.728

2.  Gene expression of cytokines and cytokine receptors is modulated by the common variability of the mitochondrial DNA in cybrid cell lines.

Authors:  Dina Bellizzi; Paola Cavalcante; Daniela Taverna; Giuseppina Rose; Giuseppe Passarino; Stefano Salvioli; Claudio Franceschi; Giovanna De Benedictis
Journal:  Genes Cells       Date:  2006-08       Impact factor: 1.891

3.  The complex pathology of osteoarthritis: even mitochondria are involved.

Authors:  Helmtrud I Roach
Journal:  Arthritis Rheum       Date:  2008-08

4.  mtDNA haplogroups and osteoarthritis in different geographic populations.

Authors:  A Soto-Hermida; M Fernández-Moreno; N Oreiro; C Fernández-López; I Rego-Pérez; F J Blanco
Journal:  Mitochondrion       Date:  2014-03-12       Impact factor: 4.160

5.  Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis.

Authors:  I Rego-Pérez; M Fernández-Moreno; M Deberg; S Pértega; C Fernández-López; N Oreiro; Y Henrotin; F J Blanco
Journal:  Ann Rheum Dis       Date:  2010-12-21       Impact factor: 19.103

6.  Defining radiographic incidence and progression of knee osteoarthritis: suggested modifications of the Kellgren and Lawrence scale.

Authors:  David T Felson; Jingbo Niu; Ali Guermazi; Burton Sack; Piran Aliabadi
Journal:  Ann Rheum Dis       Date:  2011-09-08       Impact factor: 19.103

7.  Progression of osteoarthritis as a state of inertia.

Authors:  David Felson; Jingbo Niu; Burton Sack; Piran Aliabadi; Charles McCullough; Michael C Nevitt
Journal:  Ann Rheum Dis       Date:  2012-06-30       Impact factor: 19.103

8.  Genetic, clinical and radiographic signs in knee osteoarthritis susceptibility.

Authors:  Luigi Minafra; Valentina Bravatà; Michele Saporito; Francesco P Cammarata; Giusi I Forte; Salvatore Caldarella; Michele D'Arienzo; Maria C Gilardi; Cristina Messa; Filippo Boniforti
Journal:  Arthritis Res Ther       Date:  2014-04-09       Impact factor: 5.156

9.  Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration.

Authors:  M Cristina Kenney; Marilyn Chwa; Shari R Atilano; Janelle M Pavlis; Payam Falatoonzadeh; Claudio Ramirez; Deepika Malik; Tiffany Hsu; Grace Woo; Kyaw Soe; Anthony B Nesburn; David S Boyer; Baruch D Kuppermann; S Michal Jazwinski; Michael V Miceli; Douglas C Wallace; Nitin Udar
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  Role of mtDNA haplogroups in the prevalence of knee osteoarthritis in a southern Chinese population.

Authors:  Hezhi Fang; Xinwei Liu; Lijun Shen; Fengjie Li; Yihong Liu; Hongbo Chi; Huikai Miao; Jianxin Lu; Yidong Bai
Journal:  Int J Mol Sci       Date:  2014-02-14       Impact factor: 5.923

View more
  14 in total

Review 1.  Genome Engineering for Osteoarthritis: From Designer Cells to Disease-Modifying Drugs.

Authors:  Yun-Rak Choi; Kelsey H Collins; Jin-Woo Lee; Ho-Jung Kang; Farshid Guilak
Journal:  Tissue Eng Regen Med       Date:  2019-01-05       Impact factor: 4.169

2.  Incident hand OA is strongly associated with reduced peripheral blood leukocyte telomere length.

Authors:  T McAlindon; M Roberts; J Driban; L Schaefer; I K Haugen; S E Smith; J Duryea; D Cunha; F Blanco; J-L Fernández-Garcia; C Eaton
Journal:  Osteoarthritis Cartilage       Date:  2018-08-30       Impact factor: 6.576

Review 3.  Mitochondrial DNA haplogroups participate in osteoarthritis: current evidence based on a meta-analysis.

Authors:  Zhenxing Zhao; Yifei Li; Mengjiao Wang; Ying Jin; Wen Liao; Zhihe Zhao; Jie Fang
Journal:  Clin Rheumatol       Date:  2020-01-03       Impact factor: 2.980

Review 4.  Role of mitochondria in mediating chondrocyte response to mechanical stimuli.

Authors:  Yuchen He; Meagan J Makarczyk; Hang Lin
Journal:  Life Sci       Date:  2020-10-18       Impact factor: 5.037

5.  Cartilage Metabolism, Mitochondria, and Osteoarthritis.

Authors:  Francisco J Blanco; Ronald K June
Journal:  J Am Acad Orthop Surg       Date:  2020-03-15       Impact factor: 4.000

6.  MtDNA meta-analysis reveals both phenotype specificity and allele heterogeneity: a model for differential association.

Authors:  Shani Marom; Michael Friger; Dan Mishmar
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

7.  Some patients (and some of us) respond better to some biological therapies: the as yet unsolved conundrum.

Authors:  Isabel Andia; Nicola Maffulli
Journal:  J Orthop Traumatol       Date:  2018-08-20

Review 8.  Mitochondrial Genetics and Epigenetics in Osteoarthritis.

Authors:  Ignacio Rego-Pérez; Alejandro Durán-Sotuela; Paula Ramos-Louro; Francisco J Blanco
Journal:  Front Genet       Date:  2020-01-17       Impact factor: 4.599

Review 9.  Genetic biomarkers in osteoarthritis: a quick overview.

Authors:  Ignacio Rego-Pérez; Francisco J Blanco; Alejandro Durán-Sotuela; Paula Ramos-Louro
Journal:  Fac Rev       Date:  2021-11-10

10.  Environmental factors modulated ancient mitochondrial DNA variability and the prevalence of rheumatic diseases in the Basque Country.

Authors:  I M Laza; M Hervella; M Neira Zubieta; C de-la-Rúa
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.